Europe (WHO region) vs Saint Kitts and Nevis: New cases tested for RR-/MDR-TB
Europe (WHO region)
88.0%
in 2024
Saint Kitts and Nevis
100.0%
in 2019
Europe (WHO region) rank
3rd
Saint Kitts and Nevis rank
1st
New cases tested for RR-/MDR-TB over time
- Europe (WHO region)
- Saint Kitts and Nevis
How they compare
Saint Kitts and Nevis currently reports 100.0% against 88.0% in Europe (WHO region), a difference of 12.0%.
That makes Saint Kitts and Nevis's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 1 time across 6 shared years of data; in 2010 it was Europe (WHO region) ahead.
Europe (WHO region) ranks 3rd and Saint Kitts and Nevis ranks 1st of 11 groups.
Europe (WHO region) has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Europe (WHO region) or Saint Kitts and Nevis?
- Saint Kitts and Nevis, at 100.0% against 88.0% in Europe (WHO region) as of 2019.
- What is the difference in new cases tested for rr-/mdr-tb between Europe (WHO region) and Saint Kitts and Nevis?
- 12.0%, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Europe (WHO region) and Saint Kitts and Nevis?
- 6 years are reported by both, from 2010 to 2019.
- How do Europe (WHO region) and Saint Kitts and Nevis rank globally for new cases tested for rr-/mdr-tb?
- Europe (WHO region) ranks 3rd and Saint Kitts and Nevis ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.